Efficacy and Safety of Ventilator Assisted Preoxygenation for Intubation in Two Australian Emergency Departments: A Retrospective Cohort Study.

Authors

Amy Lee, Victoria Varley, Christopher Davis, Philip Jones, Steven Grant, Gerben Keijzers, Richard Pellatt

Published in

Emergency medicine Australasia : EMA. Volume 38. Issue 5. Pages e70345.

Abstract

This study describes the incidence of first-pass intubation without hypoxaemia in patients who underwent endotracheal intubation using ventilator assisted preoxygenation (VAPOX).
Retrospective cohort study of adult patients who underwent VAPOX assisted endotracheal intubation between February 2021 and June 2025 in two EDs. The primary outcome was intubation with first-pass success (FPS) without hypoxaemia (SpO₂ < 90%). Secondary outcomes included FPS, adverse events (hypoxia, hypotension, aspiration) and oxygenation trajectories (SpO₂ and FiO₂) pre- and post-intubation.
Of the 116 patients who received VAPOX, 78% (90/116; 95% CI 69%-84%) had FPS without hypoxaemia. Overall FPS occurred in 91% (105/116; 95% CI 84%-95%). Hypoxaemia (SpO₂ < 90%) occurred in 17% (20/116; 95% CI 11%-25%), including 11% (13/116; 95% CI 7%-18%) with severe hypoxaemia (SpO₂< 85%) and 6% (7/116; 95% CI 3%-12%) with critical hypoxaemia (SpO₂< 80%). Half of all patients experienced at least one complication (58/116; 50%, 95% CI 41%-59%). Post-intubation hypotension (systolic blood pressure [SBP] < 90 mmHg) occurred in 36% of patients. No reported incidences of aspiration. Respiratory failure was the most common indication for intubation (60%) and was independently associated with a lower likelihood of success (OR 0.14; 95% CI 0.04-0.52).
We describe a cohort of patients who received VAPOX assisted ED intubation with a FPS without hypoxaemia of 78%. This was a critically ill cohort, with 46% of patients having oxygen saturations < 90% in the hour prior to intubation. These findings provide a benchmark for ED intubation using VAPOX and a comparison for future research.

PMID:
42754264
Bibliographic data and abstract were imported from PubMed on 18 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.